SMAD3 and non-small cell lung carcinoma: A biopsy study of early-stage NSCLC found that SMAD3 phosphorylation in T cell populations and in macrophages in the TME negatively impacted overall and partially disease-free survival, although SMAD3 activation in neutrophils was not assessed16.